Ribbon-like structures result when amphotericin B interacts with lipid in an aqueous environment. At high ratios of amphotericin to lipid these structures, which are lipid-stabilized amphotericin aggregates, become prevalent resulting in a dramatic attenuation of amphotericin-mediated mammalian cell, but not fungal cell, toxicity. Studies utilizing freeze-etch electron microscopy, differential scanning calorimetry, "P NMR, x-ray diffraction, and optical spectroscopy revealed that this toxicity attenuation is related to the macromolecular structure of the complexes in a definable fashion. It is likely that amphotericin in this specific form will have a much improved therapeutic utility.
Amphotericin B, a polyene antibiotic, is the drug ofchoice for a variety of systemic fungal infections that were almost always fatal prior to its introduction (1) . The cytotoxic mechanism of this compound has been the subject of intensive investigation over many years and is thought to reside in its ability to form membrane ion channels particularly in the presence of sterols (2) . That these channels and associated lethal permeability changes occur at somewhat lower membrane concentrations in the presence of ergosterol (the predominant sterol in fungal cell membranes) rather than cholesterol (the predominant sterol in mammalian cell membranes) most likely forms the basis of the selective toxicity of this drug (3) . Still, in its present dosage form, which is a deoxycholate micelle, its clinical utility is profoundly limited by host cell toxicity particularly in those cases (such as in patients with acquired immunodeficiency syndrome) where high-dose therapy is indicated.
Much attention has focused on liposome suspensions containing 5-10 mol % amphotericin B because these systems have been shown to produce a significant attenuation of toxicity with little compromise to efficacy (4) (5) (6) (7) . In fact one such formulation in which amphotericin comprises 5 mol % of a 1,2-dimyristoyl-sn-glycero(3)phosphocholine/1,2-dimyristoyl-sn-glycero(3)phospho(1)-rac-glycerol ([Myr2] PtdCho/[Myr2]PtdGro) suspension, 7:3 (mol/mol), has shown great promise in human clinical trials (8, 9) . Unfortunately, the mechanistic foundations allowing this promise have remained obscure despite attempts to elucidate them. For instance, suggestions that altered tissue distributions might play a primary role have been confounded by direct pharmacodynamic measurements (10) and demonstrations that similar toxicity attenuations can occur in vitro (11 PtdGro at a molar ratio of 7:3 was deposited from chloroform as a thin film on the bottom ofa 500-ml round-bottomed flask by rotoevaporation. This film was solubilized in 100 ml of amphotericin B in methanol (0.1 mg/ml) and again rotoevaporated to a thin film. When dry, the film was suspended in isotonic phosphatebuffered saline (PBS) and subjected to bath sonication for 0.5 hr or until particles exhibiting Brownian motion were observed by phase-contrast microscopy.
Sucrose Density Centrifugation. Typically, 200 gl of material was layered onto a continuous sucrose gradient in 150 mM NaCI/20 mM Hepes, pH 7.4. The gradient was centrifuged for 22 hr at 22TC in a SW 60 rotor (Beckman) at 230,000 x g. After centrifugation the gradient was fractionated into 150-,ul aliquots and assayed for amphotericin B (from absorbance at 412 nm in dimethylformamide) and phospholipid (from phosphate assay after digestion).
In Vivo Toxicity. LD50 values were determined by the method of Reed and Muench (12) . Female Swiss Webster mice (22-24 g) received 0.5 ml of material by intravenous injections, and lethality was registered for 10 days. A total of six mice were used at each dosage level.
In Vitro Toxicity. GBq). Differential Scanning Calorimetry. Measurements were carried out on an MC-1 unit from Micro Cal (Amherst, MA). Sample volumes of 0.70 ml containing 17-25 mg of lipid were injected into the sample cell with the same volume of buffer used in the reference cell. Samples were heated at either 260C per hr or 370C per hr. Duplicate runs of the same sample with the same history gave onset and completion temperatures reproducible to 0.2°C. In some cases, samples containing amphotericin were heated to 60°C (and no higher) and then cooled to 2-4°C for at least 2 hr prior to rescanning.
31P NMR. Spectra were obtained at 145.7 MHz on a Bruker AM360 wide-bore NMR spectrometer with 8000 data points for acquisition, a sweep width of 50 kHz, and a pulse width of 20 msec corresponding to a 450 pulse. Spectra were accumulated from up to 10,000 transients at 250C.
Wide-Angle X-Ray Diffraction. X-ray diffraction measurements were performed as described (13) .
Absorbance Spectroscopy. In all cases samples were placed in 1-cm path-length polymethacrylate cells and spectra were acquired at a scan rate of 100 nm/min on a Beckman model 35 spectrophotometer. Fig. 1 As shown in Fig. 1 B and C, these preparations produced density profiles in which the amphotericin was associated with >95% of the available lipid in a single band. Remarkably, elevating the mol fraction ofamphotericin from 5 to 50% of the bulk lipid resulted in a dramatic decrease in toxicity as indicated in Fig. 2 . When the mol fraction of amphotericin exceeded that of the lipid, however, toxicity increased to levels close to those determined for free amphotericin (100 mol %). Similar toxicity profiles were acquired in an in vitro hemolysis model, but efficacy as judged in an in vivo candidiasis model was comparatively unchanged by manipulating drug/lipid molar ratios. These experiments convinced us that to understand the underlying molecular mechanisms operating in these dispersions a more biophysical approach would be necessary. Fig. 3 (ANGSTROMSP) 1/3.6 increased in the bulk lipid. The effective chemical shift anisotropies were determiend to be 41 ppm for the 0 mol % sample, 67 ppm for the 5 mol % sample, 87 ppm for the 25 mol % sample, and 106 ppm for the 50 mol % sample. This would be expected to result from progressively immobilized lipid (16) and clearly suggested that the dampening of the endothermic behavior observed in the differential scanning calorimetry studies arose from phenomena other than just the destruction of the cooperative unit. Without a doubt, wide-angle x-ray diffraction measurements provided a rich source of data in the characterization ofthe lipid component of these systems. Pure [Myr2]PtdCho/ [Myr2]PtdGro, 7:3 (mol/mol), and the 5, 25, and 50 mol % amphotericin samples were studied at 20'C, 250C, and 40'C (Fig. 5) . At 200C the pure lipid system exhibited a relatively sharp peak at -4.2 A characteristic of the well-ordered side-by-side packing of the hydrocarbon chains in gel-phase lipid. When the sample temperature was raised to 250C, this peak was replaced by a weaker diffuse band suggesting, as had the calorimetry, that a gel to liquid crystalline transition had occurred. When 5 mol % or greater amphotericin was incorporated into the bulk lipid, however, the 4.2-A peak was evident at 20'C and 250C signaling the persistence of gelphase lipid. Again these results were foreshadowed by the 31p NMR and differential scanning calorimetry studies that detected motionally restricted lipid in these samples. At 400C there was no evidence of gel-phase lipid in the 0 and 5 mol % systems, but unmelted lipid was clearly present in the 25 and 50 mol % samples. Thus, the differential scanning calorimetry, 31P NMR, and wide-angle x-ray diffraction data supported a model in which the amphotericin at increasing mol fractions caused a progressive trans rotational isomerization or "freezing out" of the bulk lipid.
RESULTS AND DISCUSSION
We next turned our attention to the aggregation state of the amphotericin itself. We reasoned that as the mol fraction of lipid decreased in our preparations the amphotericin would become increasingly aggregated. Such aggregation phenomena have been detected by absorbance spectroscopy (17) and we applied these principles here. As shown in Fig. 6 (Upper) absorbance at longer wavelengths was attenuated as the mol fraction of amphotericin increased in the bulk lipid phase. This is consistent with increased chromophore aggregation or stacking and can be interpreted in terms of exciton splitting The 25 mol % preparations before (-) and after (---) heating for 0.5 hr at 60'C. *-, superimposable spectra arising from 5, 25, and 50 mol % samples diluted 1:10 in 4% (wt/vol) deoxycholate. (18) . Fig. 6 (Lower) shows that when these systems were solubilized in deoxycholate, absorbance rebounded and was, in fact, equivalent in all preparations. Thus it appeared to us that in carrier systems the toxicity of the amphotericin could be related simply to its aggregation state. Clearly this aggregation was enhanced in a lipid compared to deoxycholate matrix. Moreover, in the lipid environment, the aggregation was further enhanced (with a further decrease in toxicity) when the mol fraction of amphotericin was increased.
By this hypothesis, we endeavored to manipulate the physical and toxicological properties of the 25 mol % system. Fig. 4 shows that, when this sample was heated to 60'C for 0.5 hr, a pretransition and a main transition reappeared on the calorimetric tracing, implying a phase separation of the lipid. Subsequent to this lipid phase separation an increase in amphotericin B aggregation was expected and was confirmed optically as shown in Fig. 6 . Heating clearly produced a decreased absorbance consistent with an aggregation of the amphotericin chromophore as discussed above. We thus expected this heat-aggregated amphotericin system to exhibit an attenuation in toxicity, and in fact this turned out to be the case. As shown in Fig. 2 , heating of the 25 mol % sample resulted in an increase in LD50 from between 10 and 15 mg/kg to >19 mg/kg.
The studies described here thus strongly suggest that nonliposomal-lipid-stabilized aggregates of amphotericin are responsible, at least in part, for the toxicity attenuation that has been widely reported to result from the incorporation of this drug into intact vesicles (4-7). In fact, in our hands pure [Myr2]PtdCho and [Myr2]PtdGro were able to promote ribbon structures and similar toxicity attenuations compared to the [Myr2]PtdCho/[Myr2]PtdGro, 7:3 (mol/mol), mixed system we have focused on here. Our findings are supported by earlier 2H NMR studies that also suggest that even in low mol fraction mixtures with [Myr2]PtdCho, amphotericin exists in an aggregated 1:1 molar complex with lipid (19). These aggregates, which are highly ordered and limit the aqueous diffusion of amphotericin (data not shown), provide a simple structural rationale for the lipid-dependent toxicity attenuation of amphotericin. This rationale offers mechanistic insights into the source of the selective toxicity of the amphotericin-lipid complex and a means, as we have shown here, for the production of less-toxic dosage forms.
